Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001744329-24-000005·IMMUCELL CORP /DE/
Schedule 13D ownership disclosure
IMMUCELL CORP /DE/
Common Stock · CUSIP: 452525306
Event date: 2024-09-17
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- SRK FUND I, LPReported CIK 0001744329
Shares: 502,258.00 · Class: 6.4%
- SRK Capital, LLC
Shares: 502,258.00 · Class: 6.4%
- Sean Kirkwood
Shares: 502,258.00 · Class: 6.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001744329-24-000005
- Form type
- SCHEDULE 13D/A
- Filer
- IMMUCELL CORP /DE/
- CIK
- CIK 811641
- Filed
- Sep 17, 2024
- Reporting period
- Sep 17, 2024
- Description
- Schedule 13D beneficial ownership